POS0078 Comparing Methotrexate Monotherapy With Methotrexate Plus Leflunomide Combination Therapy In Psoriatic Arthritis: A Randomised, Placebo-Controlled, Double-Blind Clinical Trial (Complete-PsA)

Mulder, M.L.M., Vriezekolk, J.E., Van Hal, T. et al. (7 more authors) (2022) POS0078 Comparing Methotrexate Monotherapy With Methotrexate Plus Leflunomide Combination Therapy In Psoriatic Arthritis: A Randomised, Placebo-Controlled, Double-Blind Clinical Trial (Complete-PsA). In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , p. 259.

Metadata

Authors/Creators:
  • Mulder, M.L.M.
  • Vriezekolk, J.E.
  • Van Hal, T.
  • Nieboer, L.
  • Den Broeder, N.
  • De Jong, E.M.G.J.
  • Den Broeder, A.
  • Van den Hoogen, F.
  • Helliwell, P.
  • Wenink, M.
Dates:
  • Published (online): 23 May 2022
  • Published: 23 May 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 22 Aug 2023 13:02
Last Modified: 22 Aug 2023 13:02
Status: Published
Publisher: BMJ
Identification Number: https://doi.org/10.1136/annrheumdis-2022-eular.2042
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)